0
     

Report Added
Report already added
Long Acting Insulins Market, Global Outlook and Forecast 2022-2028

Long Acting Insulins Market, Global Outlook and Forecast 2022-2028

Long Acting Insulins (are also called basal or background insulins) can control blood sugar for an entire day. Bovine PZI (protamine zinc insulin), can last anywhere up to 36 hours. Long acting insulins are available in animal and analogue forms. They can be used for a number of different types of diabetes.
This report contains market size and forecasts of Long Acting Insulins in Global, including the following market information:

Global Long Acting Insulins Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Long Acting Insulins market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Insulin Glargine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Long Acting Insulins include Novo Nordisk, Sanofi and Wockhardt UK, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Long Acting Insulins companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Long Acting Insulins Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Long Acting Insulins Market Segment Percentages, by Type, 2021 (%)
Insulin Glargine
Insulin Determir
Insulin Degludec
Long Acting Animal Insulin
Global Long Acting Insulins Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Long Acting Insulins Market Segment Percentages, by Application, 2021 (%)
Home Use
Medical Institutions
Others
Global Long Acting Insulins Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Long Acting Insulins Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Long Acting Insulins revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Long Acting Insulins revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
Sanofi
Wockhardt UK
Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Long Acting Insulins Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Long Acting Insulins Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Long Acting Insulins Overall Market Size
2.1 Global Long Acting Insulins Market Size: 2021 VS 2028
2.2 Global Long Acting Insulins Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Long Acting Insulins Players in Global Market
3.2 Top Global Long Acting Insulins Companies Ranked by Revenue
3.3 Global Long Acting Insulins Revenue by Companies
3.4 Top 3 and Top 5 Long Acting Insulins Companies in Global Market, by Revenue in 2021
3.5 Global Companies Long Acting Insulins Product Type
3.6 Tier 1, Tier 2 and Tier 3 Long Acting Insulins Players in Global Market
3.6.1 List of Global Tier 1 Long Acting Insulins Companies
3.6.2 List of Global Tier 2 and Tier 3 Long Acting Insulins Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Long Acting Insulins Market Size Markets, 2021 & 2028
4.1.2 Insulin Glargine
4.1.3 Insulin Determir
4.1.4 Insulin Degludec
4.1.5 Long Acting Animal Insulin
4.2 By Type - Global Long Acting Insulins Revenue & Forecasts
4.2.1 By Type - Global Long Acting Insulins Revenue, 2017-2022
4.2.2 By Type - Global Long Acting Insulins Revenue, 2023-2028
4.2.3 By Type - Global Long Acting Insulins Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Long Acting Insulins Market Size, 2021 & 2028
5.1.2 Home Use
5.1.3 Medical Institutions
5.1.4 Others
5.2 By Application - Global Long Acting Insulins Revenue & Forecasts
5.2.1 By Application - Global Long Acting Insulins Revenue, 2017-2022
5.2.2 By Application - Global Long Acting Insulins Revenue, 2023-2028
5.2.3 By Application - Global Long Acting Insulins Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Long Acting Insulins Market Size, 2021 & 2028
6.2 By Region - Global Long Acting Insulins Revenue & Forecasts
6.2.1 By Region - Global Long Acting Insulins Revenue, 2017-2022
6.2.2 By Region - Global Long Acting Insulins Revenue, 2023-2028
6.2.3 By Region - Global Long Acting Insulins Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Long Acting Insulins Revenue, 2017-2028
6.3.2 US Long Acting Insulins Market Size, 2017-2028
6.3.3 Canada Long Acting Insulins Market Size, 2017-2028
6.3.4 Mexico Long Acting Insulins Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Long Acting Insulins Revenue, 2017-2028
6.4.2 Germany Long Acting Insulins Market Size, 2017-2028
6.4.3 France Long Acting Insulins Market Size, 2017-2028
6.4.4 U.K. Long Acting Insulins Market Size, 2017-2028
6.4.5 Italy Long Acting Insulins Market Size, 2017-2028
6.4.6 Russia Long Acting Insulins Market Size, 2017-2028
6.4.7 Nordic Countries Long Acting Insulins Market Size, 2017-2028
6.4.8 Benelux Long Acting Insulins Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Long Acting Insulins Revenue, 2017-2028
6.5.2 China Long Acting Insulins Market Size, 2017-2028
6.5.3 Japan Long Acting Insulins Market Size, 2017-2028
6.5.4 South Korea Long Acting Insulins Market Size, 2017-2028
6.5.5 Southeast Asia Long Acting Insulins Market Size, 2017-2028
6.5.6 India Long Acting Insulins Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Long Acting Insulins Revenue, 2017-2028
6.6.2 Brazil Long Acting Insulins Market Size, 2017-2028
6.6.3 Argentina Long Acting Insulins Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Long Acting Insulins Revenue, 2017-2028
6.7.2 Turkey Long Acting Insulins Market Size, 2017-2028
6.7.3 Israel Long Acting Insulins Market Size, 2017-2028
6.7.4 Saudi Arabia Long Acting Insulins Market Size, 2017-2028
6.7.5 UAE Long Acting Insulins Market Size, 2017-2028
7 Players Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Corporate Summary
7.1.2 Novo Nordisk Business Overview
7.1.3 Novo Nordisk Long Acting Insulins Major Product Offerings
7.1.4 Novo Nordisk Long Acting Insulins Revenue in Global Market (2017-2022)
7.1.5 Novo Nordisk Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Long Acting Insulins Major Product Offerings
7.2.4 Sanofi Long Acting Insulins Revenue in Global Market (2017-2022)
7.2.5 Sanofi Key News
7.3 Wockhardt UK
7.3.1 Wockhardt UK Corporate Summary
7.3.2 Wockhardt UK Business Overview
7.3.3 Wockhardt UK Long Acting Insulins Major Product Offerings
7.3.4 Wockhardt UK Long Acting Insulins Revenue in Global Market (2017-2022)
7.3.5 Wockhardt UK Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Long Acting Insulins Market Opportunities & Trends in Global Market
Table 2. Long Acting Insulins Market Drivers in Global Market
Table 3. Long Acting Insulins Market Restraints in Global Market
Table 4. Key Players of Long Acting Insulins in Global Market
Table 5. Top Long Acting Insulins Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Long Acting Insulins Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Long Acting Insulins Revenue Share by Companies, 2017-2022
Table 8. Global Companies Long Acting Insulins Product Type
Table 9. List of Global Tier 1 Long Acting Insulins Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Long Acting Insulins Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Long Acting Insulins Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Long Acting Insulins Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Long Acting Insulins Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Long Acting Insulins Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Long Acting Insulins Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Long Acting Insulins Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Long Acting Insulins Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Long Acting Insulins Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Long Acting Insulins Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Long Acting Insulins Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Long Acting Insulins Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Long Acting Insulins Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Long Acting Insulins Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Long Acting Insulins Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Long Acting Insulins Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Long Acting Insulins Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Long Acting Insulins Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Long Acting Insulins Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Long Acting Insulins Revenue, (US$, Mn), 2023-2028
Table 30. Novo Nordisk Corporate Summary
Table 31. Novo Nordisk Long Acting Insulins Product Offerings
Table 32. Novo Nordisk Long Acting Insulins Revenue (US$, Mn), (2017-2022)
Table 33. Sanofi Corporate Summary
Table 34. Sanofi Long Acting Insulins Product Offerings
Table 35. Sanofi Long Acting Insulins Revenue (US$, Mn), (2017-2022)
Table 36. Wockhardt UK Corporate Summary
Table 37. Wockhardt UK Long Acting Insulins Product Offerings
Table 38. Wockhardt UK Long Acting Insulins Revenue (US$, Mn), (2017-2022)

List of Figures
Figure 1. Long Acting Insulins Segment by Type in 2021
Figure 2. Long Acting Insulins Segment by Application in 2021
Figure 3. Global Long Acting Insulins Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Long Acting Insulins Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Long Acting Insulins Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Long Acting Insulins Revenue in 2021
Figure 8. By Type - Global Long Acting Insulins Revenue Market Share, 2017-2028
Figure 9. By Application - Global Long Acting Insulins Revenue Market Share, 2017-2028
Figure 10. By Region - Global Long Acting Insulins Revenue Market Share, 2017-2028
Figure 11. By Country - North America Long Acting Insulins Revenue Market Share, 2017-2028
Figure 12. US Long Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Long Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Long Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Long Acting Insulins Revenue Market Share, 2017-2028
Figure 16. Germany Long Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 17. France Long Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Long Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Long Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Long Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Long Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Long Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Long Acting Insulins Revenue Market Share, 2017-2028
Figure 24. China Long Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Long Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Long Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Long Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 28. India Long Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Long Acting Insulins Revenue Market Share, 2017-2028
Figure 30. Brazil Long Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Long Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Long Acting Insulins Revenue Market Share, 2017-2028
Figure 33. Turkey Long Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Long Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Long Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Long Acting Insulins Revenue, (US$, Mn), 2017-2028
Figure 37. Novo Nordisk Long Acting Insulins Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sanofi Long Acting Insulins Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Wockhardt UK Long Acting Insulins Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Report Title: Long Acting Insulins Market, Global Outlook and Forecast 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW